Functional relationship between cationic amino acid transporters and Β-defensins: Implications for dry skin diseases and the dry eye

Annals of Anatomy

Volumn 192, Issue 2, 2010, Pages 65-69

  Jäger, Kristin ^a   Garreis, Fabian ^a   Posa, Andreas ^a   Dunse, Matthias ^a   Paulsen, Friedrich P ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Defensins; Cationic amino acid transporter; Inflammatory diseases; L arginine; L lysine; Ocular surface

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; BETA DEFENSIN 5; LYSINE; ORNITHINE;

AMINO ACID TRANSPORT; ATOPIC DERMATITIS; DRY EYE; DRY SKIN; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; PSORIASIS; SHORT SURVEY; SKIN WATER LOSS; STAPHYLOCOCCUS INFECTION; TRANSPORT KINETICS;

AMINO ACID TRANSPORT SYSTEMS, BASIC; ARGININE; BETA-DEFENSINS; BIOLOGICAL TRANSPORT; CHILD, PRESCHOOL; DEFENSINS; DRY EYE SYNDROMES; HUMANS; LYSINE; PSORIASIS; REFRACTIVE ERRORS; SKIN DISEASES; UREA; VISION DISORDERS; VISUAL ACUITY;

EID: 77950521695     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2010.01.006     Document Type: Short Survey

References (51)

1. Baum J. Infection of the eye. Clin. Infect. Dis. 1995, 21:479-488.
2. Beisswenger C., Bals R. Functions of antimicrobial peptides in host defense and immunity. Curr. Protein Pept. Sci. 2005, 6:255-264.
3. Brennan N.A., Chantal Coles M.L. Extended wear in perspective. Invest. Ophthalmol. Vis. Sci. 1997, 74:609-623.
4. Choy M.H., Stapleton F., Willcox M.D., Zhu H. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. J. Med. Microbiol. 2008, 57(12):1539-1546.
5. +-independent transport. J. Biol. Chem. 1969, 25:1497-1504.
6. Closs E.I., Albritton L.M., Kim J.W., Cunningham J.M. Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J. Biol. Chem. 1993, 268:7538-7544.
7. Closs E.I., Gräf P., Habermeier A., Cunningham J.M., Förstermann U. Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry 1997, 36:6462-6468.
8. Collarani E.J., Oxender D.L. Mechanism of transport of amino acid across membranes. Ann. Rev. Nutr. 1987, 7:75-90.
9. DeGeorge G.L., Heck D.E., Laskin J.D. Arginine metabolism in keratinocytes and macrophages during nitric oxide biosynthesis. Biochem. Pharmacol. 1997, 54:103-112.
10. Deves R., Boyd C.A.R. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 1998, 78:478-545.
11. Fleisig S.M.J., Efron N., Pier G.B. Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human corneal epithelium. Invest. Ophthalmol. Vis. Sci. 1992, 33:2908-2916.
12. Freitas D., Alvarenga L., Sampaio J., Mannis M., Sato E., Sousa L., Vieira L., Yu M.C., Martins M.C., Hoffling-Lima A., Belfort R. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003, 110(2):276-285.
13. Ganz T., Weiss J. Antimicrobial peptides of phagocytes and epithelia. Semin. Hematol. 1997, 34:343-354.
14. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
15. Garg P., Bansal A.K., Sharma S., Vemuganti G.K. Bilateral infectious keratitis after laser in situ keratomileusis: a case report and review of the literature. Ophthalmology 2001, 108(1):121-125.
16. Gritz D.C., Whitcher J.P. Topical issues in the treatment of bacterial keratitis. Int. Ophthalmol. Clin. 1998, 38:107-114.
17. Harder J., Bartels J., Christiphers E., Schröder J.M. Isolation and characterization of human beta defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276:5707-5713.
18. Harder J., Bartels J., Christophers E., Schröder J.M. A peptide antibiotic from human skin. Nature 1997, 387:861.
19. Harder J., Siebert R., Zhang Y., Matthiesen P., Christophers E., Schlegelberger B., Schröder J.M. Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics 1997, 46(3):472-475.
20. Hoshide R., Ikeda Y., Karamshima S., Matsuura T., Komaki S., Kishino T., Niikawa N., Endo F., Matsuda I. Molecular cloning, tissue distribution, and chromosomal localization of human cationic amino acid transporter 2 (HCAT2). Genomics 1996, 38:174-178.
21. Hosokawa H., Ninomiya H., Sawamura T., Sugimoto Y., Ichikawa A., Fujiwara K., Masaki T. Neuron-specific expression of cationic amino acid transporter 3 in the adult rat brain. Brain Res. 1999, 838:158-165.
22. Hosokawa H., Sawamura T., Kobayashi S., Ninomiya H., Miwa S., Masaki T. Cloning and characterization of a brain-specific cationic amino acid transporter. Brain Res. 1997, 272:8717-8722.
23. Ito K., Groudine M. A new member of cationic amino acid transporter family is referentially expressed in adult mouse brain. J. Biol. Chem. 1997, 272:26780-26786.
24. Jaeger K., Boenisch U., Risch M., Worlitzsch D., Paulsen F.P. Detection of cationic amino acid transporters in the human lacrimal system and their involvement in ocular surface disease. Invest. Ophthalmol. Vis. Sci. 2009, 50:1112-1121.
25. Jaeger K., Paulsen F., Wohlrab J. Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. Histochem. Cell Biol. 2008, 129:321-329.
26. Kakuda D.K., Sweet M.J., MacLeod C.L., Hume D.A., Markovich D. CAT-2 mediated arginine transport and nitric oxide production in activated macrophages. Biochem. J. 1999, 340:549-553.
27. Kim J.W., Closs E.I., Albritton L.M., Cunningham J.M. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 1991, 352:725-728.
28. Krisanaprakornkit S., Kimball J.R., Weinberg A., Darveau R.P., Bainbridge B.W., Dale B.A. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 2000, 68:2907-2915.
29. Ky W., Scherick K., Stenson S. Clinical survey of lense in contact lense patients. CLAO J. 1998, 24:216-219.
30. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 1999, 11:23-27.
31. Lehrer R.I. Primate defensins. Nat. Rev. Microbiol. 2004, 2:727-738.
32. Levartovsky S., Rosenwasser G., Goodman D. Bacterial keratitis following laser in situ keratomileusis. Ophthalmology 2001, 108:321-325.
33. Lucotti P., Setola E., Monti L.D., Galluccio E., Costa S., Sandoli E.P., Fermo I., Rabaiotti G., Gatti R., Piatti P. Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab. 2006, 291:906-912.
34. McDermott A.M. Defensins and other antimicrobial peptides at the ocular surface. Ocul. Surf. 2004, 2:229-247.
35. McDermott A.M. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 2009, 41(2):60-75. (Akinci, A., Cakar, N., Kara, N., Uncu, N., 2009. Ocular findings in children with chronic renal failure. Cornea 28, 5-6).
36. Nicholson B., Manner C.K., Kleeman J., MacLeod C.L. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J. Biol. Chem. 2001, 276:15881-15885.
37. Nicolas P., Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 1995, 49:277-304.
38. O'Callaghan R.J., Cellegan M.C., Moreau J.M., Green L.C., Foster T.J., Hartford O.M., Engel L.S., Hill J.M. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect. Immun. 1997, 65:1571-1578.
39. Patrzykat A., Douglas S.E. Antimicrobial peptides: cooperative approaches to protection. Protein Pept. Lett. 2005, 12:19-25.
40. Paulsen F., et al. Antimicrobial peptides at the ocular surface. Immunology of the Lacrimal Gland, Tear Film and Ocular Surface 2005, 97-104. Taylor & Francis, London. D. Varoga, D. Steven, T. Pufe (Eds.).
41. Perkins C.P., Mar V., Shutter J.R., del Castillo J., Danilenko D.M., Medlock E.S., Ponting I.L., Graham M., Stark K.L., Zuo Y., Cunninham J.M., Bosselmann R.A. Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT. Genes Dev. 1997, 11:914-925.
42. Rahman A., Yahya K., Ahmed T., Sharif-Ul-Hasan K. Diagnostic value of tear films tests in type 2 diabetes. J. Pak. Med. Assoc. 2007, 57(12):577-581.
43. Rau G., Seedor J.A., Shah M.K., Ritterband D.C., Koplin R.S. Incidence and clinical characteristics of enterococcus keratitis. Cornea 2008, 27(8):895-899.
44. Recker K., Klapperstück T., Kehlen A., Wohlrab J. The importance of cationic amino acid transporter expression in human skin. J. Invest. Dermatol. 2003, 121:1552-1553.
45. Schröder J.M. Antimikrobielle peptide - antibiotika der Zukunft?. Med.. Monatsschr. Pharm. 1999, 22(270-276):66.
46. Schröder J.M. Epithelial peptide antibiotics. Biochem. Pharmacol. 1999, 57:121-134.
47. Vekony N., Wolf S., Boissel J.P., Gnauert K., Closs E.I. Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissue. Biochemistry 2001, 40:12387-12394.
48. Wang H., Kavanaugh M.P., North R.A., Kabat D. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 1991, 352:729-731.
49. Wellner K., Fiedler G., Wohlrab W. Untersuchungen zum harnstoffgehalt der hornschicht bei neurodermitis. Z. Hautkr. 1992, 67:648-650.
50. Yamaguchi Y., Nagase T., Makita R., Fukuhara S., Tomita T., Tominaga T., Kurihara H., Ouchi Y. Identification of multiple novel epididymis-specific Β-defensin isoforms in human and mice. J. Immunol. 2002, 169:2516-2523. (Akinci, A., Cetinkaya, E., Aycan, Z., 2007. Dry eye syndrome in diabetic children. Eur. J. Ophthalmol. 17, 873-878).
51. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002, 23:291-296.